Dear editor,As mentioned in the article in question, the selected control group had 21 volunteers
without skin diseases and without gastrointestinal symptoms.[1] This group was composed of people with similar
socioeconomic status as the patients and who were accompanying those patients during the
visits or who had been attended at a neighboring outpatient clinic. We agree that our
control group had a small number of participants because of the difficulty in getting
healthy people willing to undergo blood collection without any material gain in
return.The methods for the diagnosis of Helicobacter pylori are divided into
invasive and non-invasive. In our study, we used the Elisa serological test, a
noninvasive method ideal for epidemiological studies, based on the identification of
H. pylori-specific IgG antibodies in the patient's serum. However,
the has some restrictions. It only detects host exposure to the bacterium, without
diagnosing active infection (true infection) (Krogfelt et al.,
2005).[2] We chose this method
due to its reduced cost and the low complexity of accomplishment in relation to other
diagnostic methods. We believe that the patient's contact with H.
pylori alone is sufficient to trigger the immunological cascade implicated
in the pathogenesis of psoriasis. As in our study, Qayoom and Ahmad detected H.
pylori antibodies in 40% of psoriasispatients and 10% of control subjects
(healthy subjects without gastrointestinal complaints) and concluded that H.
pylori plays a causal role in the pathogenesis of psoriasis.[3] Similarly, Fathy et al.
compared 20 plaque psoriasispatients with 20 healthy volunteers, matched for age and
gender, and tested them for H. pilory antibodies using the Elisa test.
The mean prevalence of seropositivity in psoriaticpatients was significantly higher
when compared to controls. Also, the high values correlated with the severity of the
disease. They concluded that there is a link between H. pylori and
psoriasis and that the bacterium may also influence the pathogenesis of the
disease.[4]
Authors: Priscila Miranda Diogo Mesquita; Augusto Diogo; Miguel Tanus Jorge; Alceu Luiz Camargo Villela Berbert; Sônia Antunes de Oliveira Mantese; José Joaquim Rodrigues Journal: An Bras Dermatol Date: 2017 Jan-Feb Impact factor: 1.896
Authors: Antonietta Gerarda Gravina; Rocco Maurizio Zagari; Cristiana De Musis; Lorenzo Romano; Carmelina Loguercio; Marco Romano Journal: World J Gastroenterol Date: 2018-08-07 Impact factor: 5.742